Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt No Debt
MOTS's Cash-to-Debt is ranked higher than
74% of the 261 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.52 vs. MOTS: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
MOTS' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.27  Med: No Debt Max: No Debt
Current: No Debt
0.27
No Debt
Equity-to-Asset 0.80
MOTS's Equity-to-Asset is ranked lower than
99.99% of the 239 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 0.61 vs. MOTS: 0.80 )
Ranked among companies with meaningful Equity-to-Asset only.
MOTS' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.6  Med: 0.8 Max: 0.84
Current: 0.8
0.6
0.84
Altman Z-Score: -2.41
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -37980.00
MOTS's Operating Margin % is ranked lower than
99.99% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.59 vs. MOTS: -37980.00 )
Ranked among companies with meaningful Operating Margin % only.
MOTS' s Operating Margin % Range Over the Past 10 Years
Min: -185200  Med: -185200 Max: -37980
Current: -37980
-185200
-37980
Net Margin % -45471.11
MOTS's Net Margin % is ranked lower than
99.99% of the 241 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -2.48 vs. MOTS: -45471.11 )
Ranked among companies with meaningful Net Margin % only.
MOTS' s Net Margin % Range Over the Past 10 Years
Min: -188571.43  Med: -188571.43 Max: -45471.11
Current: -45471.11
-188571.43
-45471.11
ROE % -187.46
MOTS's ROE % is ranked lower than
93% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -6.75 vs. MOTS: -187.46 )
Ranked among companies with meaningful ROE % only.
MOTS' s ROE % Range Over the Past 10 Years
Min: -254.46  Med: -212.11 Max: -169.75
Current: -187.46
-254.46
-169.75
ROA % -141.71
MOTS's ROA % is ranked lower than
93% of the 262 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -4.54 vs. MOTS: -141.71 )
Ranked among companies with meaningful ROA % only.
MOTS' s ROA % Range Over the Past 10 Years
Min: -349.33  Med: -123.6 Max: -115.39
Current: -141.71
-349.33
-115.39
ROC (Joel Greenblatt) % -2524.56
MOTS's ROC (Joel Greenblatt) % is ranked lower than
93% of the 259 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -9.57 vs. MOTS: -2524.56 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
MOTS' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -5293.29  Med: -3794.27 Max: -2524.56
Current: -2524.56
-5293.29
-2524.56
GuruFocus has detected 1 Warning Sign with Motus GI Holdings Inc MOTS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» MOTS's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

MOTS Guru Trades in

MOTS Guru Trades in

MOTS Guru Trades in

Q3 2018

MOTS Guru Trades in Q3 2018

Jim Simons 27,300 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with MOTS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Motus GI Holdings Inc does not have enough historical financial data to display Peter Lynch Chart.

Business Description

Industry: Medical Diagnostics & Research » Diagnostics & Research    NAICS: 334517    SIC: 3845
Compare:AMEX:VNRX, ROCO:6598, OSL:GENT-ME, XKRX:109820, NAS:ITUS, NAS:FLGT, LSE:AGL, SGX:1B1, TPE:4155, ASX:VHT, ROCO:6615, XKRX:084650, XKRX:238120, XPAR:CLNV, BOM:524394, XTER:LIO1, WAR:VOX, TSE:3386, OTCPK:GTBP, NAS:VRML » details
Headquarter Location:USA
Motus GI Holdings Inc is a medical technology company that develops single-use medical device system, the Pure-Vu system. It is designed to assist in the early detection of colorectal cancer and other diseases of the rectum and colon.

Motus GI Holdings Inc is engaged in diagnostics and research business sector. It is a medical technology company that develops a single-use medical device system called the Pure-Vu system. The device is used to cure colorectal cancer and other diseases of the rectum and colon. The system facilitates intraprocedural cleaning of a poorly prepared colon by irrigating, cleaning the colon, evacuating the irrigation fluid (water), feces, and other bodily fluids and matter.

Ratios

vs
industry
vs
history
PB Ratio 5.43
MOTS's PB Ratio is ranked lower than
70% of the 245 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.02 vs. MOTS: 5.43 )
Ranked among companies with meaningful PB Ratio only.
MOTS' s PB Ratio Range Over the Past 10 Years
Min: 3.87  Med: 6.38 Max: 11.25
Current: 5.43
3.87
11.25
PS Ratio 1090.00
MOTS's PS Ratio is ranked lower than
99.99% of the 230 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 3.81 vs. MOTS: 1090.00 )
Ranked among companies with meaningful PS Ratio only.
MOTS' s PS Ratio Range Over the Past 10 Years
Min: 1090  Med: 2046.67 Max: 5340
Current: 1090
1090
5340
EV-to-EBIT -1.93
MOTS's EV-to-EBIT is ranked lower than
99.99% of the 118 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 25.06 vs. MOTS: -1.93 )
Ranked among companies with meaningful EV-to-EBIT only.
MOTS' s EV-to-EBIT Range Over the Past 10 Years
Min: -7  Med: -2.8 Max: -1.93
Current: -1.93
-7
-1.93
EV-to-EBITDA -1.94
MOTS's EV-to-EBITDA is ranked lower than
99.99% of the 132 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 20.75 vs. MOTS: -1.94 )
Ranked among companies with meaningful EV-to-EBITDA only.
MOTS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -7.1  Med: -2.8 Max: -1.94
Current: -1.94
-7.1
-1.94
EV-to-Revenue 881.75
MOTS's EV-to-Revenue is ranked lower than
99.99% of the 242 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 4.24 vs. MOTS: 881.75 )
Ranked among companies with meaningful EV-to-Revenue only.
MOTS' s EV-to-Revenue Range Over the Past 10 Years
Min: 922.8  Med: 1803.55 Max: 3037
Current: 881.75
922.8
3037
Current Ratio 5.23
MOTS's Current Ratio is ranked higher than
89% of the 250 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.58 vs. MOTS: 5.23 )
Ranked among companies with meaningful Current Ratio only.
MOTS' s Current Ratio Range Over the Past 10 Years
Min: 2.11  Med: 9.18 Max: 15.94
Current: 5.23
2.11
15.94
Quick Ratio 5.21
MOTS's Quick Ratio is ranked higher than
90% of the 250 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 2.14 vs. MOTS: 5.21 )
Ranked among companies with meaningful Quick Ratio only.
MOTS' s Quick Ratio Range Over the Past 10 Years
Min: 2.11  Med: 8.79 Max: 15.83
Current: 5.21
2.11
15.83
Days Inventory 755.98
MOTS's Days Inventory is ranked lower than
99.99% of the 204 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 79.76 vs. MOTS: 755.98 )
Ranked among companies with meaningful Days Inventory only.
MOTS' s Days Inventory Range Over the Past 10 Years
Min: 755.98  Med: 5292.5 Max: 5292.5
Current: 755.98
755.98
5292.5
Days Sales Outstanding 186.56
MOTS's Days Sales Outstanding is ranked lower than
99.99% of the 204 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 67.51 vs. MOTS: 186.56 )
Ranked among companies with meaningful Days Sales Outstanding only.
MOTS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0  Med: 0 Max: 186.56
Current: 186.56
0
186.56
Days Payable 8.00
MOTS's Days Payable is ranked lower than
99.99% of the 187 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 63.34 vs. MOTS: 8.00 )
Ranked among companies with meaningful Days Payable only.
MOTS' s Days Payable Range Over the Past 10 Years
Min: 8  Med: 107310 Max: 107310
Current: 8
8
107310

Buy Back

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 7.11
MOTS's Price-to-Net-Cash is ranked lower than
99.99% of the 86 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 14.60 vs. MOTS: 7.11 )
Ranked among companies with meaningful Price-to-Net-Cash only.
MOTS' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.57  Med: 9.72 Max: 11.09
Current: 7.11
4.57
11.09
Price-to-Net-Current-Asset-Value 6.06
MOTS's Price-to-Net-Current-Asset-Value is ranked lower than
99.99% of the 147 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 10.88 vs. MOTS: 6.06 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
MOTS' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.31  Med: 8.99 Max: 9.44
Current: 6.06
4.31
9.44
Price-to-Tangible-Book 5.45
MOTS's Price-to-Tangible-Book is ranked lower than
51% of the 207 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 6.46 vs. MOTS: 5.45 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MOTS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.06  Med: 8.35 Max: 8.47
Current: 5.45
4.06
8.47
Price-to-Median-PS-Value 0.53
MOTS's Price-to-Median-PS-Value is ranked lower than
99.99% of the 193 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 1.01 vs. MOTS: 0.53 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MOTS' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53  Med: 1.17 Max: 2.19
Current: 0.53
0.53
2.19
Earnings Yield (Greenblatt) % -51.85
MOTS's Earnings Yield (Greenblatt) % is ranked lower than
72% of the 265 Companies
in the Global Diagnostics & Research industry.

( Industry Median: -0.98 vs. MOTS: -51.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MOTS' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -51.85  Med: -35.35 Max: -14.2
Current: -51.85
-51.85
-14.2

More Statistics

Revenue (TTM) (Mil) $0.05
EPS (TTM) $ -1.17
52-Week Range $3.03 - 10.66
Shares Outstanding (Mil)15.69

Analyst Estimate

Dec18 Dec19 Dec20 Dec21
Revenue (Mil $) 8 31 56
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) -1.28 -1.27 -0.86 -0.29
EPS without NRI ($) -1.28 -1.27 -0.86 -0.29
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}